Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry ; volume:13 ; number:1 ; day:16 ; month:11 ; year:2022 ; pages:187-206 ; date:1.2023
Dermatology and therapy ; 13, Heft 1 (16.11.2022), 187-206, 1.2023
- Urheber
-
Yu, Chen
Wang, Gang
Burge, Russel T.
Ye, Erjia
Dou, Guanshen
Li, Jinnan
Harrison, Ryan W.
McLean, Robert R.
Kerti, Samantha J.
Bagel, Jerry
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-022-00843-6
- URN
-
urn:nbn:de:101:1-2023031522131364116597
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yu, Chen
- Wang, Gang
- Burge, Russel T.
- Ye, Erjia
- Dou, Guanshen
- Li, Jinnan
- Harrison, Ryan W.
- McLean, Robert R.
- Kerti, Samantha J.
- Bagel, Jerry
- SpringerLink (Online service)
Ähnliche Objekte (12)
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
The effects of quantitative easing announcements on the mortgage market: An event study approach
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis?
Mirror patterns of physical variables in the ocean
Random exponential attractor for a stochastic reaction-diffusion equation in L 2 p ( D ) $L^2p}(D)$
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
The effects of quantitative easing announcements on the mortgage market: An event study approach
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis?
Mirror patterns of physical variables in the ocean
Random exponential attractor for a stochastic reaction-diffusion equation in L 2 p ( D ) $L^2p}(D)$
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
The effects of quantitative easing announcements on the mortgage market: An event study approach
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis?
Mirror patterns of physical variables in the ocean